PV Hawk provides life sciences organizations with a tool to quickly and securely overcome their challenges with accurate data analysis while fulfilling the responsibility of patient safety.

LOS ANGELES (PRWEB)
May 19, 2020

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, today announced that Perficient, Inc.(“Perficient”), a global digital consultancy transforming the world’s largest enterprises and biggest brands, has been selected as the winner of the “Best Data Visualization Solution” award for its pharmacovigilance intelligence application, PV Hawk, in the fourth annual MedTech Breakthrough Awards program.

Regulatory authorities worldwide have requirements in place for marketing authorization holders to monitor the safety and risk-benefit profile of their products for potential signals and trends, resulting in volumes of data that can make accurate analysis challenging. Perficient’s PV Hawk allows pharmaceutical and medical device companies to quickly aggregate data in real time across all their safety surveillance practices. Data is displayed in a modern visual format (Hawk Visuals) for the surveillance of trends. Using PV Hawk, life science organizations can perform sophisticated risk-benefit analysis, compare same-in-class drugs used for similar indications, and analyze the impact a drug can have with other drug and disease interactions.

“We are thrilled to receive this 2020 MedTech Breakthrough Award in honor of the product innovation and success of the PV Hawk platform,” said Dr. Kari Blaho-Owens, director of safety and pharmacovigilance, Perficient. “PV Hawk provides life sciences organizations with a tool to quickly and securely overcome their challenges with accurate data analysis while fulfilling the responsibility of patient safety.”

PV Hawk is optimized to help life sciences organizations in all phases of clinical trials, including post-marketing surveillance, and is versatile enough to work across regulatory environments, such as animal health, nutraceuticals, and cosmetovigilance. Users have the option to license the product and use it on their own, or they can partner with Perficient to perform an analysis on an as-needed basis.

“Data analysis is essential when it comes to appreciating the impact of drugs and medical devices on one’s health. Look no further than the race to develop or find a vaccine, treatment, and ultimately a cure for COVID-19,” said Dr. Blaho-Owens. “With a data visualization tool like PV Hawk, any company can overlay its clinical and safety data with data from other sources, including the FDA Adverse Event Reporting System (FAERS), to perform a risk-benefit analysis and determine the potential efficacy of its current drugs for COVID-19.”

“Across all industries, especially in life sciences, we increasingly see the need to analyze data more effectively,” said James Johnson, managing director, MedTech Breakthrough. “PV Hawk demonstrates how potential trends can be presented through visualization without spending time running complex database queries or chasing false positives. We are proud to recognize PV Hawk as a ‘breakthrough’ in the data visualization space, and we look forward to continued innovation and success from Perficient.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,750 nominations from over 15 different countries throughout the world.

####

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

About Perficient

Perficient is a leading global digital consultancy. We imagine, create, engineer and run digital transformation solutions that help our clients exceed customers’ expectations, outpace competition, and grow their business. With unparalleled strategy, creative and technology capabilities, we bring big thinking and innovative ideas, along with a practical approach to help the world’s largest enterprises and biggest brands succeed. Traded on the Nasdaq Global Select Market, Perficient is a member of the Russell 2000 index and the S&P SmallCap 600 index. Perficient is an award-winning Adobe Platinum Partner, Platinum Level IBM business partner, a Microsoft National Service Provider and Gold Certified Partner, an Oracle Platinum Partner, a Gold Salesforce Consulting Partner, a Sitecore Platinum Partner, and a VMware Authorized Partner. For more information, visit http://www.perficient.com.

Share article on social media or email:

iTero® Element 5D Imaging System Awarded “Best New Technology Solution for Dentistry” in 2020 MedTech Breakthrough Awards

Building on a successful track record of dental technology innovation, from its Invisalign® System that revolutionized teeth straightening, Align continues driving innovation in the dental industry with its iTero Element 5D.

LOS ANGELES (PRWEB)
May 19, 2020

MedTech Breakthrough, an independent market intelligence organization that recognizes the top technology product companies in the global health and medical technology market, announced today that it has selected Align Technology, Inc. (Nasdaq: ALGN) as the winner of the “Best New Technology Solution for Dentistry” award for its iTero Element® 5D Imaging System (“iTero Element 5D”) in its fourth annual MedTech Breakthrough Awards program.

The iTero Element 5D, the latest innovation in the iTero product portfolio, is the first integrated dental imaging system that simultaneously records 3D intra-oral optical impressions, 2D color images, and Near Infrared images (NIRI). With the iTero Element 5D, full arch scans can be completed in as little as 60 seconds.*

iTero Element 5D’s NIRI technology scans the structure (enamel and dentin) of a tooth in real time, without harmful radiation, acting as a digital aid for detection of interproximal caries.**

Through iTero Element 5D’s visualization tools, patients can see and better understand their current dental health issues, their treatment plan options, and simulated outcomes directly on-screen at the doctor’s office, enabling education and compliance during treatment, and an overall better patient experience.

“Given the importance of oral health to everyone’s overall health, it’s not surprising that dental technologies are an important component of the larger MedTech Breakthrough category,” said James Johnson, managing director, MedTech Breakthrough. “Align is a strong leader in the dental technology space, and we recognize its “breakthrough” dental imaging platform for dentists and orthodontists. Building on a successful track record of dental technology innovation, from its Invisalign® System that revolutionized teeth straightening, Align continues driving innovation in the dental industry with its iTero Element 5D. We extend a hearty congratulations to Align for its well-deserved industry recognition with this 2020 MedTech Breakthrough Award designation.”

The goal of the MedTech Breakthrough Awards is to honor excellence and recognize innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,750 nominations from over 15 different countries throughout the world.

“We are honored to receive the 2020 MedTech Breakthrough Award and believe it is a powerful testament to the innovative technology and overall results the iTero platform delivers to doctors and their patients,” said Yuval Shaked, senior vice president and managing director, iTero scanner and services business, Align Technology. “Prior to the iTero Element 5D launch, separate caries detection devices existed as a complement to x-rays and required practitioners to make additional investments on top of their existing x-ray technology and created inefficient chairside workflows. By seamlessly combining three key scanning technologies – 3D optical impressions, 2D oral color photos, and NIRI – into one, single integrated scan, the iTero Element 5D increases the efficiency and interconnectedness of the dentists’ workflow dramatically.”

####

*Data on file at Align Technology, as of February 10, 2017.

**Data on file at Align Technology, as of December 4, 2018.

Information about the iTero Element 5D Imaging System can be found at http://www.itero.com/en/products/itero_element_5d

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and CAD/CAM software. Align has helped treat over 8 million patients with the Invisalign system and is driving the evolution in digital dentistry with the iTero intraoral scanner and exocad CAD/CAM software − modernizing today’s practices by enabling enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies. Visit http://www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit http://www.invisalign.com. For additional information about the iTero digital scanning system, please visit http://www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit http://www.exocad.com.

Share article on social media or email:

We congratulate Zebra Technologies for tackling the complex task of simplifying and streamlining workflow efficiency, and we extend a hearty congratulations to the entire Zebra team for winning the ‘Best Clinical Administration Hardware Device’ award.

LOS ANGELES (PRWEB)
May 19, 2020

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Zebra Technologies Corporation, an innovator at the edge of the enterprise with solutions and partners that enable businesses to gain a performance edge, has been selected as the winner of the “Best Clinical Administration Hardware Device” award for its DS9908R-HD hybrid imager.

Labs and healthcare facilities can use the DS9908R-HD imager to safely scan and track 2D barcodes found on critical items, such as medications, blood, tissue and biopsy samples. These identity solutions help ensure safety by accurately identifying patients, medications, specimens and hospital assets. In addition, the DS9908R-HD can read securPharm labels, which are used to protect patients from receiving counterfeit medications. With the right disinfectants, medical workers can also wipe down the DS9908R-HD to ensure they are limiting the spread of infectious diseases in their facilities.

The DS9908R-HD offers a one-of-a-kind hybrid design and management tools to drive workflow efficiency. The hybrid design enables seamless switching between handheld and hands-free scanning, allowing the technology to adapt to the desired workflow instead of forcing workers to adjust their processes to suit the technology. This ensures specimens are dealt with in a timely fashion and prescriptions are filled quickly and accurately, thus increasing patient safety. The healthcare-grade hybrid scanner also comes with a proven and reliable design increasing the scanner’s durability and dependability.

The DS9908R-HD offers an optional RFID model and further boosts staff efficiency by reading multiple RFID-tagged samples in one pass without line of sight. Its high-density focus is purposely designed for the healthcare environment and ensures workers can read a variety of barcodes, including smaller high-density barcodes often found on microscope slides, medicine bottles and blood vials.

“Pharmacists and lab technicians often face daunting workloads, and we know that increasing efficiencies in their workflows directly results in improved patient outcomes,” said Chris Sullivan, Global Healthcare Practice Lead, Zebra Technologies. “We are thrilled to be recognized three years in a row with a 2020 MedTech Breakthrough designation for Best Clinical Administration Hardware Device.”

This year’s accolade marks Zebra’s third consecutive year receiving a MedTech Breakthrough Award, demonstrating its commitment to providing innovative barcode scanning, RFID, mobile computing and software solutions to the healthcare industry. In 2019, Zebra’s TC52-HC touch computer was awarded “Best Clinical Efficiency Solution.” In 2018, Zebra’s TC51-HC earned the “Best Overall mHealth Hardware Solution” award while its Lifeguard for Android™ security solution was recognized as “Best Healthcare Network Security Solution.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,750 nominations from over 15 different countries throughout the world.

“Streamlining workflow in pharmacies and labs, particularly labs that specialize in vital patient specimens like tissue and bloodwork, is an extremely important aspect of the healthcare industry as a whole,” said James Johnson, managing director, MedTech Breakthrough. “We congratulate Zebra Technologies for tackling the complex task of simplifying and streamlining workflow efficiency, and we extend a hearty congratulations to the entire Zebra team for winning the ‘Best Clinical Administration Hardware Device’ award. We look forward to witnessing Zebra as it continues to push the healthcare industry forward with “breakthrough” MedTech innovation.”

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

About Zebra

Zebra (NASDAQ: ZBRA) empowers the front line of business in retail/e-commerce, manufacturing, transportation and logistics, healthcare and other industries to achieve a performance edge. With more than 10,000 partners across 100 countries, we deliver industry-tailored, end-to-end solutions that intelligently connect people, assets, and data to help our customers make business-critical decisions. Our market-leading solutions elevate the shopping experience, track and manage inventory as well as improve supply chain efficiency and patient care. In 2019, Zebra ranked #166 on Forbes’ list of the World’s Best Employers, and the company joined the S&P 500 index.  For more information, visit zebra.com or sign up for our news alerts.

Follow us on our Your Edge Blog along with LinkedIn, Twitter and Facebook.

Share article on social media or email:

DrOwl’s free groundbreaking solution can help to protect the employees, vendors, patients, and their loved ones by providing early detection to help mitigate risks and protect our most vulnerable members of the community for the benefit for everyone.

ALBUQUERQUE, N.M. (PRWEB)
May 19, 2020

DrOwl, a medical platform built on patented technology, today announced the rollout of a free new electronic screening and monitoring solution to help protect people at businesses, facilities, and nursing homes in the face of COVID-19. We hope that making this free electronic screening and monitoring solution available will help to mitigate the risks throughout this pandemic and beyond.

Outbreaks of the coronavirus at American businesses and nursing homes across the nation have spurred urgent cries for precautionary measures. The CDC recommends that visitors and employees who have symptoms such as cough, fever, or shortness of breath should be separated from other employees or not be allowed to enter. In order to find out if their employees and visitors have these symptoms, many organizations currently screen people coming into their business through paper tracking. This paper tracking system is inefficient and may not help prevent further infections.

DrOwl will now be providing a groundbreaking solution to this problem, with a platform that electronically screens and tracks everyone who enters businesses, facilities, and nursing homes, creating an electronic tracking of all employees and visitor activity in real-time. This free screening and monitoring tool allows businesses to screen their employees, vendors and (if they so choose) their customers, in order to keep their workforces and facilities as safe as possible during the difficult period. Although nothing is foolproof, good methods of screening can help keep everyone stay safe and may reduce a business’s potential liability from any exposure or outbreak at their facility.

Using the DrOwl app or a webpage customized to each facility, each employee, visitor or vendor is asked questions such as “have you had flu-like symptoms in the last 14 days.” Each business or facility can customize the questions asked for their facility. They can also get an electronic log of each visitor and how they answered the questions. If the visitor answers that they are feeling fine and have not been exposed, they are allowed to enter right away. If the visitor answers they have been feeling bad, had a fever, etc., they are given a message customed by the facility. For example, if an employee answers that they have a fever, they can be instructed to leave the facility and to a COVID-19 test.

“DrOwl created this screening tool with the intent of helping organizations screen people coming into their facilities to potentially save lives”, said Arvind Raichur, CEO, and Co-Founder of DrOwl. “We understand the severity of COVID-19 and wanted to do our part in helping provide resources to help our community and those around the nation during this trying time. The electronic screening tool in DrOwl can play a critical role in helping give businesses the ability to screen people who may have COVID-19, so that they will not infect more people.”

In addition to the free electronic monitoring and storage solution, DrOwl also provides a safe, encrypted, HIPAA-compliant place to store your medical records all in one convenient place. The platform was built on patented technology to store, organize, search, and share your digital medical records on demand.

Once a user securely stores their medical records, DrOwl uses AI and machine learning to provide users with a Patient Portal based on the Patient’s health records that includes trusted, doctor-approved sources of information that is customized for each user. DrOwl users can also share their Patient Portal with caregivers or family members to include them in the patient’s healthcare decisions. And, they can also initiate telehealth sessions, and allow their caregivers or family members to join in the secure telemedicine video call. This is currently available in select areas of Florida, with other locations coming online shortly.

Dr. Krishan Nagda, MD, the President of DrOwl, said, “As a physician, I understand how important it is to screen employees and visitors to lessen the risk of spreading COVID-19. DrOwl’s free groundbreaking solution can help to protect the employees, vendors, patients, and their loved ones by providing early detection to help mitigate risks and protect our most vulnerable members of the community for the benefit for everyone.”

Businesses can go to checkin.DrOwl.com to learn more about this technology. And, users can download DrOwl.com for free from the iTunes or Google Play app stores.

About DrOwl

DrOwl is a medical platform built on patented technology, that provides a safe place to store your medical records. It was built to store, organize, search, and share your digital medical records on demand.

Once a user securely stores their medical records, DrOwl uses AI and machine learning to provide users with a Patient Portal based on the Patient’s health records that includes trusted, doctor-approved sources of information that is customized for each user and makes their medical information easier to understand. DrOwl users can also share their customized Patient Portal with caregivers or family members to include them in the patient’s healthcare decisions. Users can initiate telehealth sessions and allow their caregivers or family members to join in the secure telemedicine video call.

DrOwl provides a free electronic screening solution to help protect businesses. DrOwl’s free screening tools allows businesses to screen their employees, vendors and visitors in order to keep their workforces and facilities as safe as possible during the difficult period.

Share article on social media or email:

Orchestra BioMed’s patented implantable cardiac stimulation-based treatment embodies the spirit of the MedTech Breakthrough Awards program, representing innovation with significant implications for the field of cardiac rhythm management

LOS ANGELES (PRWEB)
May 19, 2020

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing transformative therapeutic products for large unmet needs in procedure-based medicine, has been selected as the winner of the “Best New Therapeutic Technology Award” for the Company’s BackBeat Cardiac Neuromodulation Therapy (CNT) in the fourth annual MedTech Breakthrough Awards program.

BackBeat CNT™ is a patented bioelectronic treatment that delivers an immediate, substantial and sustained reduction in blood pressure while simultaneously modulating the autonomic nervous system. Results from MODERATO II, the prospective, randomized, double-blind, multicenter study demonstrated that BackBeat CNT drove a statistically significant and clinically meaningful reduction in 24-hour ambulatory systolic blood pressure (ASBP) versus control in hypertensive patients who are also indicated for a pacemaker.

“With high blood pressure affecting approximately 1 out of 3 Americans, BackBeat CNT is a much needed “breakthrough” approach to device-based blood pressure management,” said James Johnson, managing director, MedTech Breakthrough. “Orchestra BioMed’s patented implantable cardiac stimulation-based treatment embodies the spirit of the MedTech Breakthrough Awards program, representing innovation with significant implications for the field of cardiac rhythm management. We are thrilled to recognize Orchestra BioMed for their well-deserved success and innovation with BackBeat CNT.”

Hypertension (elevated blood pressure) is a condition that increases the risk of major cardiac events such as heart attack and stroke and can also contribute to other significant conditions such as heart failure and kidney disease. According to the World Health Organization (WHO), hypertension is the leading global risk factor for death and it is estimated to afflict 1.13 billion adults worldwide. In the United States, 116.4 million adults, or approximately 46% of all adults, are estimated to have hypertension, according to the American Heart Association.

BackBeat CNT mimics the effects of multi-drug hypertension therapy by targeting preload, afterload and sympathetic tone. Orchestra BioMed’s CE Mark-approved Moderato® implantable pulse generator system delivers BackBeat CNT while also providing standard pacemaker functions. Over 1.1 million pacemakers are implanted annually worldwide and over 70% of pacemaker patients suffer from hypertension alongside other comorbidities and risk factors. Because BackBeat CNT can be readily incorporated into a standard pacemaker device without requiring a change to hardware or implantation technique, treatment of hypertensive patients also indicated for pacemaker is a compelling initial clinical application of this novel therapy.

“We are honored to receive industry recognition for our BackBeat CNT therapy,” said David Hochman, chairman, CEO and founder of Orchestra BioMed. “This award validates the potential therapeutic significance of our patented cardiac neuromodulation therapy for hypertensive patients and acknowledges our team’s ability to execute on our mission of bringing medical innovations to life. We look forward to continuing to advance the development of this exciting new therapy and forging strategic collaborations that enable it to reach patients worldwide.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,750 nominations from over 15 different countries throughout the world.

####

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

About Orchestra BioMed™

Orchestra BioMed is a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine. The Company is led by a highly accomplished, multidisciplinary management team and board of directors with extensive experience in all phases of medical device development. Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops. Orchestra BioMed was formed in 2018 by assembling a pipeline of multiple late-stage clinical product candidates originally developed by the Company’s founding team. The Company’s flagship product candidates are Virtue® Sirolimus AngioInfusion™ Balloon (SAB) for the treatment of artery disease, the leading cause of mortality, and BackBeat Cardiac Neuromodulation Therapy™ for the treatment of hypertension, the leading risk factor for death worldwide. Orchestra BioMed has a global strategic partnership with Terumo Corporation, one of the world’s largest medical device companies, for development and commercialization of Virtue SAB. Together, the companies plan to initiate a U.S. pivotal trial for the use of Virtue SAB in the treatment of coronary in-stent restenosis in 2020 which will be the first in a series of pivotal trials aimed at achieving regulatory approvals in multiple indications worldwide. The Company has additional product candidates in its pipeline and plans to thoughtfully expand its product pipeline in the future through acquisitions, strategic collaborations, licensing and organic development.

About BackBeat CNT™

BackBeat CNT, a flagship therapy of Orchestra BioMed, is a bioelectronic treatment that immediately, substantially, and chronically lowers blood pressure (BP) while simultaneously modulating the Autonomic Nervous System (ANS). Orchestra BioMed’s CE Mark-approved Moderato® implantable pulse generator system delivers BackBeat CNT while also providing standard pacemaker functions. BackBeat CNT mimics the effects of multi-drug hypertension therapy by targeting preload, afterload and sympathetic tone. BackBeat CNT’s initial target are patients with uncontrolled hypertension who are also indicated for a pacemaker.

Share article on social media or email: